Publication:
Serum and urine levels of tumour necrosis factor in patients with genitourinary cancer and their relevance to disease status

Simple item page
dc.contributor.authorsAkdaş A., Türkeri L., Akoĝlu T.
dc.date.accessioned2022-03-15T01:47:48Z
dc.date.accessioned2026-01-11T07:59:12Z
dc.date.available2022-03-15T01:47:48Z
dc.date.issued1990
dc.description.abstractSerum and urine levels of tumour necrosis factor (TNF) which is a lymphokine was measured in patients with genitourinary cancer (either prostatic, bladder or testicular carcinoma) in order to find out whether there were elevated levels of TNF in those patients and if it was related to disease status. Although the preliminary results are not conclusive, further research on TNF may prove this immunoprotein to be a potential diagnostic and therapeutic agent. © 1990 Akadémiai Kiadó.
dc.identifier.doi10.1007/BF02549736
dc.identifier.issn3011623
dc.identifier.pubmed2093690
dc.identifier.urihttps://hdl.handle.net/11424/246180
dc.language.isoeng
dc.publisherKluwer Academic Publishers
dc.relation.ispartofInternational Urology and Nephrology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleSerum and urine levels of tumour necrosis factor in patients with genitourinary cancer and their relevance to disease status
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage506
oaire.citation.issue6
oaire.citation.startPage501
oaire.citation.titleInternational Urology and Nephrology
oaire.citation.volume22

Files

Collections

Araştırma Çıktıları